Published in Radiother Oncol on March 01, 1992
Quality control at the patient level: action or retrospective introspection. Radiother Oncol (1992) 0.77
Is it necessary to repeat quality control procedures for head and neck patients? Radiother Oncol (1991) 1.93
The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys (2000) 5.24
Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys (1998) 2.97
Gene interaction and single gene effects in colon tumour susceptibility in mice. Nat Genet (1996) 2.84
Recombinant congenic strains--a new tool for analyzing genetic traits determined by more than one gene. Immunogenetics (1986) 2.28
Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach. Radiology (1999) 2.24
Pulmonary resection for metastases of colorectal origin. Chest (1995) 2.09
Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys (1999) 2.05
Set-up verification using portal imaging; review of current clinical practice. Radiother Oncol (2001) 1.80
Prognostic factors of neck node metastasis. Clin Otolaryngol Allied Sci (1982) 1.67
Prediction of overall pulmonary function loss in relation to the 3-D dose distribution for patients with breast cancer and malignant lymphoma. Radiother Oncol (1998) 1.65
Ischemic preconditioning in cardiac surgery: a word of caution. J Thorac Cardiovasc Surg (1996) 1.60
Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys (1998) 1.58
The impact of treatment time and smoking on local control and complications in T1 glottic cancer. Int J Radiat Oncol Biol Phys (1998) 1.57
Estimation of overall pulmonary function after irradiation using dose-effect relations for local functional injury. Radiother Oncol (1995) 1.57
Insulin resistance and breast-cancer risk. Int J Cancer (1992) 1.57
Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment. Cancer (1991) 1.56
Positive iliac and obturator nodes in melanoma: survival and prognostic factors. Ann Surg Oncol (1999) 1.55
Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med (1993) 1.55
The interpretation of multiple P-values. Radiother Oncol (1994) 1.54
Lymph node metastasis from melanoma with an unknown primary site. Br J Surg (1990) 1.49
Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. Int J Radiat Oncol Biol Phys (1995) 1.49
Clear cell sarcoma (malignant melanoma) of soft parts: A clinicopathologic study of 30 cases. Cancer (1999) 1.46
The clinical spectrum and treatment of primary non-Hodgkin's lymphoma of the stomach. Ann Oncol (1993) 1.42
The potential impact of CT-MRI matching on tumor volume delineation in advanced head and neck cancer. Int J Radiat Oncol Biol Phys (1997) 1.26
Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin. Cancer Treat Rep (1984) 1.25
Resectable retroperitoneal soft tissue sarcomas. The effect of extent of resection and postoperative radiation therapy on local tumor control. Cancer (1994) 1.25
Complexity of lung cancer modifiers: mapping of thirty genes and twenty-five interactions in half of the mouse genome. J Natl Cancer Inst (2001) 1.24
Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan. Surgery (1994) 1.23
A general methodology for three-dimensional analysis of variation in target volume delineation. Med Phys (1999) 1.22
Some prognostic and epidemiologic factors in canine osteosarcoma. J Natl Cancer Inst (1979) 1.21
Brain metastases in breast cancer; natural history, prognostic factors and outcome. J Neurooncol (1993) 1.18
Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg (1997) 1.18
Fusion of respiration-correlated PET and CT scans: correlated lung tumour motion in anatomical and functional scans. Phys Med Biol (2005) 1.17
Radiation dose-effect relations and local recovery in perfusion for patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2000) 1.16
High-precision prostate cancer irradiation by clinical application of an offline patient setup verification procedure, using portal imaging. Int J Radiat Oncol Biol Phys (1996) 1.15
Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes. Genes Immun (2000) 1.12
The development of a prognostic score for patients with parotid carcinoma. Cancer (1999) 1.11
Determination of benzo[a]pyrene diol epoxide-DNA adducts in white blood cell DNA from coke-oven workers: the impact of smoking. J Natl Cancer Inst (1990) 1.11
Marfan syndrome in children and adolescents: predictive and prognostic value of aortic root growth for screening for aortic complications. Heart (1998) 1.10
Serial lumbar and ventricle cerebrospinal fluid lactate dehydrogenase activities in patients with leptomeningeal metastases from solid and haematological tumours. J Neurol Neurosurg Psychiatry (1987) 1.10
Cardiac and lung complication probabilities after breast cancer irradiation. Radiother Oncol (2000) 1.09
Tamoxifen, serum lipoproteins and cardiovascular risk. Br J Cancer (1988) 1.08
The H-reflex of the flexor carpi radialis muscle; a study in controls and radiation-induced brachial plexus lesions. J Neurol Neurosurg Psychiatry (1984) 1.08
Primary axillary radiotherapy as axillary treatment in breast-conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes. Cancer (2000) 1.07
Marfan syndrome in children and adolescents: an adjusted nomogram for screening aortic root dilatation. Heart (1998) 1.07
Stage as major long term outcome predictor in minor salivary gland carcinoma. Cancer (2000) 1.07
Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer. Int J Cancer (1995) 1.06
Nonpenetrating stapling: a valuable alternative for coronary anastomoses? Ann Thorac Surg (1998) 1.06
The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis. Radiother Oncol (1999) 1.05
Intraventricular methotrexate therapy of leptomeningeal metastasis from breast carcinoma. Neurology (1983) 1.05
Ototoxicity of cis-diamminedichloroplatinum (II): influence of dose, schedule and mode of administration. Eur J Cancer Clin Oncol (1983) 1.04
Transcriptional regulation of gamma-glutamylcysteine synthetase-heavy subunit by oxidants in human alveolar epithelial cells. Biochem Biophys Res Commun (1996) 1.04
Scc-1, a novel colon cancer susceptibility gene in the mouse: linkage to CD44 (Ly-24, Pgp-1) on chromosome 2. Oncogene (1992) 1.04
Dose-wall histograms and normalized dose-surface histograms for the rectum: a new method to analyze the dose distribution over the rectum in conformal radiotherapy. Int J Radiat Oncol Biol Phys (1999) 1.03
The prevalence of mental health problems in Rwandan and Burundese refugee camps. Acta Psychiatr Scand (2000) 1.02
Non-Hodgkin's lymphomata: clinical features in relation to histology. Br J Cancer Suppl (1975) 1.01
A verification procedure to improve patient set-up accuracy using portal images. Radiother Oncol (1993) 1.01
Dose-effect relations for early local pulmonary injury after irradiation for malignant lymphoma and breast cancer. Radiother Oncol (1998) 1.01
Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease. J Clin Oncol (1989) 1.01
On-pump, beating-heart coronary artery operations in high-risk patients: an acceptable trade-off? Ann Thorac Surg (1997) 1.00
Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis. Radiother Oncol (1998) 1.00
In regard to Tsujino et al.: predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. IJROBP 2003;55:110-115. Int J Radiat Oncol Biol Phys (2003) 0.99
3-D portal image analysis in clinical practice: an evaluation of 2-D and 3-D analysis techniques as applied to 30 prostate cancer patients. Int J Radiat Oncol Biol Phys (2000) 0.99
Identification of high-risk groups among node-positive patients with stage IB and IIA cervical carcinoma. Gynecol Oncol (1997) 0.99
Cerebrospinal fluid beta-glucuronidase activities in patients with central nervous system metastases. Clin Chim Acta (1985) 0.97
Fine mapping of colon tumor susceptibility (Scc) genes in the mouse, different from the genes known to be somatically mutated in colon cancer. Proc Natl Acad Sci U S A (1996) 0.97
Body measurements, estrogen availability and the risk of human breast cancer: a case-control study. Int J Cancer (1992) 0.97
Treatment results of primary stage I and II non-Hodgkin's lymphoma of the stomach. Radiother Oncol (1988) 0.96
Quantification of patient to patient variation of skin erythema developing as a response to radiotherapy. Radiother Oncol (1994) 0.95
Eradication of large human B cell tumors in nude mice with unconjugated CD20 monoclonal antibodies and interleukin 2. Cancer Res (1995) 0.95
Radio-immuno assay of lactoferrin in blood plasma of breast cancer patients, lactating and normal women; prevention of false high levels caused by leakage from neutrophile leucocytes in vitro. Folia Med Neerl (1972) 0.95
Prognostic factors in canine mammary cancer. J Natl Cancer Inst (1976) 0.95
The volume effect in radiation-related late small bowel complications: results of a clinical study of the EORTC Radiotherapy Cooperative Group in patients treated for rectal carcinoma. Radiother Oncol (1994) 0.95
Spread according to histology in non-Hodgkin's lymphomata. Br J Cancer Suppl (1975) 0.95
Outcome of thoracoscopic pulmonary metastasectomy evaluated by confirmatory thoracotomy. Ann Thorac Surg (2001) 0.95
The influence of age on treatment choice and survival of elderly breast cancer patients in south-eastern Netherlands: a population-based study. Eur J Cancer (1992) 0.95
A retrospective study of male breast cancer in Holland. Br J Surg (1985) 0.94
Value of resection of pulmonary metastases in head and neck cancer patients. Head Neck (1996) 0.94
Accelerated ray tracing for radiotherapy dose calculations on a GPU. Med Phys (2009) 0.94
A new method to determine dose-effect relations for local lung-function changes using correlated SPECT and CT data. Radiother Oncol (1993) 0.94
Prognostic significance of serum fragments of cytokeratin 19 measured by Cyfra 21-1 in cervical cancer. Gynecol Oncol (1994) 0.93
Provider-associated factors in obstetric interventions. Eur J Obstet Gynecol Reprod Biol (1995) 0.93
The prognostic significance of a previous malignancy in operable non-small cell lung cancer. Lung Cancer (2001) 0.93
Circadian rhythms in systemic hemodynamics and renal function in healthy subjects and patients with nephrotic syndrome. Kidney Int (2001) 0.93
Muscle-invasive bladder cancer treated with external beam radiation: influence of total dose, overall treatment time, and treatment interruption on local control. Int J Radiat Oncol Biol Phys (1998) 0.93
[Efficacy of ranitidine and cimetidine in the treatment of gastric or duodenal ulcer resistant to an initial treatment with cimetidine. Multicenter controlled therapeutic trial]. Gastroenterol Clin Biol (1985) 0.92
Setup deviations in wedged pair irradiation of parotid gland and tonsillar tumors, measured with an electronic portal imaging device. Radiother Oncol (1995) 0.92
Electronic portal imaging with on-line correction of setup error in thoracic irradiation: clinical evaluation. Int J Radiat Oncol Biol Phys (1998) 0.92
The recombinant congenic strains--a novel genetic tool applied to the study of colon tumor development in the mouse. Mamm Genome (1991) 0.91
Pharmacokinetics of melphalan in isolated perfusion of the limbs. J Pharmacol Exp Ther (1986) 0.91
Splenectomy in Hodgkin's disease and second leukaemias. Lancet (1987) 0.91
Monitoring of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in cells from platinum-treated cancer patients. Cancer Res (1988) 0.91
Prognostic factors in transitional cell cancer of the bladder: an emerging role for Bcl-2 and p53. Radiother Oncol (2001) 0.91
Influence of mouse major histocompatibility complex (H-2) on N-ethyl-N-nitrosourea-induced tumor formation in various organs. Cancer Res (1988) 0.91
Cerebrospinal fluid carcinoembryonic antigen in patients with metastatic and nonmetastatic neurological diseases. Arch Neurol (1986) 0.91